19 Feb 2024 Date | | - Cons. EPS | - EPS |
12 Feb 2024 Date | | - Cons. EPS | - EPS |
27 Nov 2023 Date | | - Cons. EPS | - EPS |
20 Nov 2023 Date | | - Cons. EPS | - EPS |
13 Nov 2023 Date | | - Cons. EPS | - EPS |
19 Feb 2024 Date | | - Cons. EPS | - EPS |
12 Feb 2024 Date | | - Cons. EPS | - EPS |
27 Nov 2023 Date | | - Cons. EPS | - EPS |
20 Nov 2023 Date | | - Cons. EPS | - EPS |
13 Nov 2023 Date | | - Cons. EPS | - EPS |
Medical - Pharmaceuticals Industry | Healthcare Sector | Lei Liu CEO | NASDAQ (CM) Exchange | G2124G120 Cusip |
CN Country | 939 Employees | - Last Dividend | 1 Mar 2024 Last Split | 16 May 2008 IPO Date |
China Jo-Jo Drugstores, Inc., established in 2003 and headquartered in Hangzhou, the People's Republic of China, operates as a prominent retailer and distributor of pharmaceutical and healthcare products. The company's operations are diversified across four main segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. With a broad network of retail pharmacies under the Jiuzhou Grand Pharmacy brand, China Jo-Jo has carved a niche for itself in the Chinese healthcare market by offering a wide range of pharmaceutical products, leveraging traditional Chinese medicines (TCM), and providing professional medical consultations and treatments.